New clinical evidence presented at PAINWeek 2026 demonstrates the powerful, long-lasting relief of TYLENOL® with Naproxen in post-surgical pain studies

Read post on prnewswire.com

TYLENOL® with Naproxen, a first-of-its-kind, non-opioid OTC option for the millions managing persistent pain, is backed by more than a decade of research, including Phase 3 data to be presented at PAINWeek In two rigorous Phase 3 clinical studies, findings demonstrated the effectiveness...